# CORRESP — BriaCell Therapeutics Corp.  (BCTX, BCTXL, BCTXZ)  (CIK 0001610820)

> <strong>BriaCell Therapeutics Corp.  (BCTX, BCTXL, BCTXZ)  (CIK 0001610820) → SEC staff</strong> · filed 2026-01-08 · ticker BCTX, BCTXL, BCTXZ · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001493152-26-000962
- **Form:** CORRESP
- **Filer:** BriaCell Therapeutics Corp.  (BCTX, BCTXL, BCTXZ)  (CIK 0001610820)
- **CIK:** 0001610820
- **Ticker:** BCTX, BCTXL, BCTXZ
- **Filed:** 2026-01-08
- **SIC industry:** 2834
- **HQ:** West Vancouver, A1

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1610820/000149315226000962/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1610820&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for BriaCell Therapeutics Corp.  (BCTX, BCTXL, BCTXZ)  (CIK 0001610820)

- CORRESP — 2026-01-08 — /comment-letter/0001493152-26-000961
- CORRESP — 2026-01-06 — /comment-letter/0001493152-26-000535
- CORRESP — 2026-01-06 — /comment-letter/0001493152-26-000533

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, BriaCell Therapeutics Corp.  (BCTX, BCTXL, BCTXZ)  (CIK 0001610820) (CIK 0001610820), filed 2026-01-08, accession 0001493152-26-000962. Retrieved via MORVS 2026-11-14 from https://api.morvs.ai/comment-letter/0001493152-26-000962.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*